KRY | LIVI

-48%

est. 2Y upside i

HealthcareSeries D+

Rank

#3236

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Low

The equity component appears to have a negative expected return of -47.8% over 2 years based on scenario analysis.

Last updated: July 21, 2026

Bull (25%)-15%

If IPO window opens and exit multiple expands to 6x forward revenue, exit value ~$1.69B, still a 15% loss from entry value.

Base (55%)-44%

Multiple converges to public comp range (4x), exit value ~$1.13B, a 44% loss.

Bear (20%)-100%

Multiple compresses to 2x, exit value below total funding ($896M), common stock recovers -100% due to preference stack.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

45%

Total funding $896M vs valuation $2B (45%), meaning preferred stock holds majority of value in exit up to $896M.

Dilution Risk

low

No likely raise within 2 years due to profitability.

Secondary Liquidity

none

No secondary market data available.

Other — 31 roles

Alla jobb · blocks--faq--item#toggle" data-blocks--faq--item-target="button" > Får jag utbildning/introduktion innan jag börjar på Kry?
Allmänläkare med möjlighet till framtida ledningsuppdrag på Kry Vårdcentral Hornstull · blocks--faq--item#toggle" data-blocks--faq--item-target="button" > Vilka steg ingår i er rekryteringsprocess?
Anders Kjell Gruppchef Kry Hornstull · blocks--faq--item#toggle" data-blocks--faq--item-target="button" > Kan jag sjukskriva patienter digitalt via Kry?
+28 more →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on KRY | LIVI's data — designed to show you've done your homework.

1
“How does Kry maintain its competitive advantage against incumbents like Doctolib?”
2
“What is the revenue breakdown between public and private payers, and how does that impact margins?”
3
“Given the layoffs in 2022, how does the company plan to achieve sustainable growth?”

Our model estimates -48% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.